{
    "Trade/Device Name(s)": [
        "GSP Neonatal IRT kit (3306-001U)",
        "GSP Neonatal IRT kit"
    ],
    "Submitter Information": "Wallac Oy, subsidiary of PerkinElmer",
    "510(k) Number": "K102419",
    "Predicate Device Reference 510(k) Number(s)": [
        "K0003668"
    ],
    "Regulatory Class": "Class I exempt, exceeds the limitation to exemption in 862.9(c)(2)",
    "Product Code(s)": [
        "JNO"
    ],
    "Summary Letter Date": "November 24, 2010",
    "Summary Letter Received Date": "November 26, 2010",
    "Submission Date": "December 9, 2010",
    "Regulation Number(s)": [
        "21CFR862.1725"
    ],
    "Regulation Name(s)": [
        "Trypsin Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Immunoreactive trypsin(ogen) (IRT)"
    ],
    "Specimen Type(s)": [
        "Blood specimens dried on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper disk (approx. 3.2 mm diameter)",
        "Filter paper cassette (Whatman no. 903)"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Solid phase two-site fluoroimmunometric assay",
        "Time-resolved fluorescence"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Plate"
    ],
    "Document Summary": "FDA 510(k) summary for the GSP Neonatal IRT kit for quantitative determination of immunoreactive trypsin(ogen) in dried blood spots to aid newborn cystic fibrosis screening",
    "Indications for Use Summary": "Quantitative determination of human immunoreactive trypsin(ogen) in blood specimens dried on filter paper as an aid in screening newborns for cystic fibrosis using the GSP instrument",
    "fda_folder": "Clinical Chemistry"
}